Evidence map›Paper›PMID 36959263›Full record

ArticleNature structural & molecular biology2023

Mechanism of receptor assembly via the pleiotropic adipokine Leptin.

Alexandra Tsirigotaki, Ann Dansercoer, Koen H G Verschueren, Iva Marković, Christoph Pollmann, Maximillian Hafer, Jan Felix, Catherine Birck, Wouter Van Putte, Dominiek Catteeuw and 5 more

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Nature structural & molecular biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
6.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Single-Molecule FRET-Tracking of InlB-Activated MET Receptors in Living Cells.Small (Weinheim an der Bergstrasse, Germany) · 2026
    Article
  3. Article
  4. Tuning of G-CSFR signaling by de novo-designed agonists.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 3 countries.

Alexandra TsirigotakiUnit for Structural Biology, Department of Biochemistry and Microbiology, Ghent University, Ghent, Belgium.
Ann DansercoerUnit for Structural Biology, Department of Biochemistry and Microbiology, Ghent University, Ghent, Belgium.
Koen H G VerschuerenUnit for Structural Biology, Department of Biochemistry and Microbiology, Ghent University, Ghent, Belgium.
Iva MarkovićUnit for Structural Biology, Department of Biochemistry and Microbiology, Ghent University, Ghent, Belgium.ORCID 0000-0003-0885-4513
Christoph PollmannDepartment of Biology/Chemistry and Center for Cellular Nanoanalytics, Osnabrück University, Osnabrück, Germany.
Maximillian HaferDepartment of Biology/Chemistry and Center for Cellular Nanoanalytics, Osnabrück University, Osnabrück, Germany.
Jan FelixUnit for Structural Biology, Department of Biochemistry and Microbiology, Ghent University, Ghent, Belgium.ORCID 0000-0002-8436-9467
Catherine BirckIntegrated Structural Biology Platform, Centre for Integrative Biology (CBI), Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), CNRS UMR 7104, INSERM U1258, University of Strasbourg, Illkirch, France.ORCID 0000-0003-1624-255X
Wouter Van PuttePUXANO BV, Ghent, Belgium.
Dominiek CatteeuwVIB-UGent Center for Medical Biotechnology, Ghent, Belgium.
Jan TavernierVIB-UGent Center for Medical Biotechnology, Ghent, Belgium.ORCID 0000-0002-7609-6462
J Fernando BazanUnit for Structural Biology, VIB-UGent Center for Inflammation Research, Ghent, Belgium.
Jacob PiehlerDepartment of Biology/Chemistry and Center for Cellular Nanoanalytics, Osnabrück University, Osnabrück, Germany.ORCID 0000-0002-2143-2270
Savvas N SavvidesUnit for Structural Biology, Department of Biochemistry and Microbiology, Ghent University, Ghent, Belgium. savvas.savvides@ugent.be.ORCID 0000-0003-3420-5947
Kenneth VerstraeteUnit for Structural Biology, Department of Biochemistry and Microbiology, Ghent University, Ghent, Belgium. kenneth.verstraete@ugent.be.ORCID 0000-0001-6544-6458
Ghent University · BEOsnabrück University · DECentre National de la Recherche Scientifique · FRUniversity College Ghent · BEVIB-UGent Center for Inflammation Research · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The adipokine Leptin activates its receptor LEP-R in the hypothalamus to regulate body weight and exerts additional pleiotropic functions in immunity, fertility and cancer. However, the structure and mechanism of Leptin-mediated LEP-R assemblies has remained unclear. Intriguingly, the signaling-competent isoform of LEP-R is only lowly abundant amid several inactive short LEP-R isoforms contributing to a mechanistic conundrum. Here we show by X-ray crystallography and cryo-EM that, in contrast to long-standing paradigms, Leptin induces type I cytokine receptor assemblies featuring 3:3 stoichiometry and demonstrate such Leptin-induced trimerization of LEP-R on living cells via single-molecule microscopy. In mediating these assemblies, Leptin undergoes drastic restructuring that activates its site III for binding to the Ig domain of an adjacent LEP-R. These interactions are abolished by mutations linked to obesity. Collectively, our study provides the structural and mechanistic framework for how evolutionarily conserved Leptin:LEP-R assemblies with 3:3 stoichiometry can engage distinct LEP-R isoforms to achieve signaling.

Indexed as

AdipokinesLeptinProtein IsoformsSignal TransductionAdipokinesLeptinProtein Isoforms

Identifiers

PMID36959263
OpenAlexW4360612246

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.